Table 3.
The 1-, 2- and 5-year survival probabilities by treatment modality and cohort from day 1 of the start of RRT/dialysis or from the day of transplantation
| Survival probabilities as percentage (95% CI) |
||||||
|---|---|---|---|---|---|---|
| Cohort: 2005–09 |
Cohort: 2008–12 |
|||||
| 1 year | 2 year | 5 year | 1 year | 2 year | ||
| Patient survival on RRT | ||||||
| Unadjusted | 82.7 (82.5–82.8) | 72.0 (71.8–72.1) | 49.4 (49.2–49.5) | 83.8 (83.6–84.0) | 73.7 (73.5–73.9) | |
| Adjusteda | 90.0 (89.9–90.2) | 82.8 (82.6–83.0) | 63.3 (63.0–63.6) | 90.6 (90.4–90.7) | 83.8 (83.6–84.0) | |
| Patient survival on dialysis (with kidney transplantation as a censored observation) | ||||||
| Unadjusted | 81.7 (81.5–81.9) | 69.7 (69.5–69.9) | 41.5 (41.3–41.6) | 82.7 (82.6–82.9) | 71.3 (71.1–71.4) | |
| Adjusteda | 88.1 (87.9–88.2) | 79.5 (79.2–79.7) | 55.7 (55.3–56.1) | 89.0 (88.9–89.2) | 81.1 (80.8–81.3) | |
| Patient survival after first kidney transplantation (deceased donor) | ||||||
| Unadjusted | 96.1 (95.8–96.3) | 94.2 (93.9–94.5) | 87.9 (87.5–88.3) | 96.4 (96.1–96.6) | 94.4 (94.1–94.6) | |
| Adjustedb | 97.6 (97.4–97.8) | 96.4 (96.2–96.6) | 92.3 (91.9–92.7) | 98.0 (97.8–98.1) | 96.8 (96.6–97.0) | |
| Graft survival after first kidney transplantation (deceased donor) | ||||||
| Unadjusted | 90.9 (90.6–91.2) | 88.1 (87.7–88.4) | 79.0 (78.6–79.4) | 91.2 (90.9–91.5) | 88.3 (88.0–88.6) | |
| Adjustedb | 92.2 (91.8–92.5) | 89.7 (89.3–90.1) | 81.6 (81.1–82.2) | 92.7 (92.4–93.0) | 90.2 (89.8–90.6) | |
| Patient survival after first kidney transplantation (living donor) | ||||||
| Unadjusted | 98.4 (98.1–98.7) | 97.5 (97.1–97.8) | 94.2 (93.7–94.7) | 98.8 (98.6–99.0) | 97.9 (97.6–98.2) | |
| Adjustedb | 98.8 (98.6–99.1) | 98.2 (97.9–98.5) | 95.7 (95.2–96.2) | 99.2 (99.0–99.3) | 98.6 (98.3–98.8) | |
| Graft survival after first kidney transplantation (living donor) | ||||||
| Unadjusted | 95.5 (95.0–95.9) | 93.6 (93.0–94.1) | 87.0 (86.4–87.7) | 96.3 (95.9–96.6) | 94.5 (94.1–94.9) | |
| Adjustedb | 95.5 (95.0–96.0) | 93.7 (93.1–94.2) | 87.0 (86.3–87.8) | 96.3 (96.0–96.7) | 94.6 (94.2–95.1) | |
This is based on data from the following registries providing individual patient data: Austria, Belgium (Dutch-speaking), Belgium (French-speaking), Denmark, Finland, France, Greece, Iceland, Norway, Spain (Andalusia), Spain (Aragon), Spain (Asturias), Spain (Basque country), Spain (Cantabria), Spain (Castile and León), Spain (Castile-La Mancha), Spain (Catalonia), Spain (Extremadura), Spain (Galicia), Spain (Valencian region), Sweden, the Netherlands and the UK (all countries).
Analyses were adjusted using fixed values: age (60 years), gender (60% men) and primary renal disease (20% diabetes mellitus, 17% hypertension/renal vascular disease, 15% glomerulonephritis and 48% other causes).
Analyses were adjusted using fixed values: age (45 years), gender (60% men) and primary renal disease (10% diabetes mellitus, 8% hypertension/renal vascular disease, 28% glomerulonephritis and 54% other causes).